Business description
aap Implantate AG is a globally operating medical device company headquartered in Berlin, Germany. The company develops, manufactures and markets trauma products for orthopedics. The IP protected portfolio includes besides the innovative anatomical plating system LOQTEQ® and trauma complementary biomaterials a wide range of cannulated screws as well as standard plates and screws. Furthermore, aap Implantate AG has an innovation pipeline with promising development projects as the antibacterial silver coating technology and magnesium based implants. These technologies address critical problems in surgery that haven’t yet been resolved adequately. In German-speaking Europe aap Implantate AG directly sells its products to hospitals, buying syndicates and hospital groups while it has a broad network of distributors in more than 20 countries at the international level.
Management board & Supervisory board
| CEO |
| Rubino Di Girolamo |
| Management board |
| Marek Hahn, Agnieszka Mierzejewska |
| Supervisory board |
| Dr. Nathalie Krebs, Jacqueline Rijsdijk, Marc Langner |
Company data
| Name: |
aap Implantate AG |
| Address: |
Lorenzweg 5,D-12099 Berlin |
| Phone: |
+49-30-75019-0 |
| Fax: |
+49-30-75019-111 |
| E-mail: |
mail@aap.de
|
| Internet: |
www.aap.de/ |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
12-31 |
| Free Float: |
50.67% |
| IPO date: |
1999-05-10 |
Investor relations
| Name: |
Fabian Franke |
| IR phone: |
+49-30-75019-134 |
| IR Fax: |
+49-30-75019-290 |
| IR e-mail: |
-
|
